Načítá se...
Factor XIIIa Inhibitors as Potential Novel Drugs for Venous Thromboembolism
Human factor XIIIa (FXIIIa) is a multifunctional transglutaminase with a significant role in hemostasis. FXIIIa catalyzes the last step in the coagulation process. It stabilizes the blood clot by cross-linking the α- and γ-chains of fibrin. It also protects the newly formed clot from plasmin-mediate...
Uloženo v:
| Vydáno v: | Eur J Med Chem |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7513741/ https://ncbi.nlm.nih.gov/pubmed/32502864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2020.112442 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|